SCHEMBL7860271

SCHEMBL7860271

Cc1nc2ccc(-c3ccc4c(c3)CN(c3ncnc5c(C)cc(Cl)cc35)CCO4)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 10/20 0.47
ALDH1A1 P00352 4/20 0.36
CYP2C19 P33261 4/20 0.36
LMNA P02545 4/20 0.36
HIF1A Q16665 4/20 0.36
CYP1A2 P05177 4/20 0.36
CYP2D6 P10635 3/20 0.36
CYP3A4 P08684 3/20 0.36
CLK4 Q9HAZ1 3/20 0.36
MAPK1 P28482 2/20 0.36
USP2 O75604 1/20 0.36
KDM4E B2RXH2 2/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TSHR P16473 1/20 0.34
S1PR2 O95136 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL856295 0.94 PIK3CA (0.47) PIK3CAALDH1A1CYP2C19LMNAHIF1A
SCHEMBL7823835 0.91 PIK3CA (0.48) PIK3CAALDH1A1CYP2C19LMNAHIF1A
SCHEMBL856212 0.90 PIK3CA (0.49) PIK3CAALDH1A1CYP2C19LMNAHIF1A
SCHEMBL855583 0.88 PIK3CA (0.49) PIK3CAALDH1A1CYP2C19LMNAHIF1A
SCHEMBL856472 0.88 PIK3CA (0.47) PIK3CAALDH1A1CYP2C19LMNAHIF1A
SCHEMBL858779 0.87 PIK3CA (0.48) PIK3CAALDH1A1CYP2C19LMNAHIF1A
SCHEMBL856159 0.87 PIK3CA (0.45) PIK3CAALDH1A1CYP2C19LMNAHIF1A
SCHEMBL856354 0.87 PIK3CA (0.47) PIK3CAALDH1A1CYP2C19LMNAHIF1A
SCHEMBL7816643 0.86 PIK3CA (0.47) PIK3CAALDH1A1CYP2C19LMNAHIF1A
SCHEMBL857459 0.85 PIK3CA (0.45) PIK3CAALDH1A1CYP2C19LMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed